NCT01293383

A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects

A Phase 1 Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects. A Single Centre, Prospective, Randomised, Double-blinded, Vehicle-controlled Clinical Study

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: LEO Pharma · Industry
• Sex: Male
• Age: 20 Years – 40 Years
• Healthy volunteers: Accepted

Summary

The purpose of this trial is to to investigate the safety of LEO 90105 compared with its vehicle after multiple administration (twice daily, 5 days) in healthy Japanese male subjects.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	LEO 90105	Ointment

Timeline

• Start date: 2011-03-01
• Primary completion: 2011-03-01
• Completion: 2011-03-01
• First posted: 2011-02-10
• Last updated: 2025-02-24

Locations

1 site across 1 country: Japan